Dr. Reddy’s Laboratories said that the European Commission (EC) has granted marketing authorisation for AVT03, a biosimilar of Prolia® (denosumab) and Xgeva® (denosumab).

Sensex Today | Stock Market LIVE Updates: The market, on expiry day, may look for support from two factors. The rebound in Wall Street is…

During this 14-day losing streak, the stock has lost nearly one-third of its value, declining 31%. On a year-to-date basis, shares of Tarsons Products are…

Stocks rose in Japan — where markets reopened after a holiday — and in South Korea. US shares advanced Monday as tech stocks extended their…

West Texas Intermediate held near $59 a barrel after gaining more than 1% in the previous session, while Brent closed above $63.

Nuvama Alternative and Quantitative Research estimates that about 18.58 crore shares will unlock for trading on November 25, accounting for roughly 20% of the company’s…

UBS Securities’ trading desk now thinks the selloff in US stocks may have run its course, especially with expectations for the Fed lowering rates next…

The US-based BlackRock’s affiliate, iShares Core MSCI Emerging Markets ETF, acquired 9.82 lakh equity shares of ACC, purchased 9.68 lakh shares of TD Power Systems…

The Indian central bank sold a net of $7.91 billion in the foreign exchange market in September, data released on Monday showed, as the Reserve…

The company said its order backlog stood at ₹16,205 crore as of September 2025, reflecting a 47% increase compared to September 2024. New orders for…